BOTH BILL n HILLARY ARE DEEPLY CORRUPTED P 3
We light on this
because there is still misinformed people who believe in their sanctity while they are ready to continue creating political
disruption with direct effect on the US economy.
#LOCKTHEMUP: What Went Wrong for Clinton Foundation's HIV/AIDS Initiative https://sputniknews.com/politics/201703101051454217-clinton-foundation-hiv-aids/
One of the Clinton Foundation's
most controversial endeavors, the HIV/AIDS initiative, was never organized or
operated lawfully at any time, Wall Street analyst Charles Ortel told Sputnik. There is no evidence that can be verified that
the 'international' charity ever lawfully provided any help to victims of
HIV/AIDS anywhere, he stressed.
Charles Ortel, a Wall Street
analyst who discovered that General Electric stock was overvalued
before the market crash in 2008, continues his investigation into the Clinton
Foundation's alleged fraud.
One of the Clintons' most
discussed and most controversial endeavors was the HIV/AIDS initiative dubbed
CHAI (The Clinton Health Access Initiative).
The charity's site says that the
initiative was aimed at "helping save the
lives of millions of people" living with Acquired
Immune Deficiency Syndrome (AIDS) and Human Immunodeficiency Virus (HIV)
in the developing world "by dramatically
scaling up antiretroviral treatment."
Something Went Wrong From the
Very Beginning the
analyst notes.
In his January interview with
DadyChery.org editor, Ortel pointed out that the Clinton Foundation's largest operation — the
HIV/AIDS initiative — was "never organized or operated
lawfully at any time."
What does it mean?
"Under US law, a
nonprofit corporation must serve carefully-defined purposes exclusively that
actually are 'tax-exempt' if it wishes to qualify and afford donors the
ability to deduct contributions made from their federal income tax returns,"
Ortel told Sputnik, commenting on the issue.
"In addition, a federally tax-exempt nonprofit corporation must
check with individual state laws and comply with these if it wishes
to offer donors the further chance to deduct contributions
from their state income tax returns," he
said.
The Clinton Foundation — first called The William J.
Clinton Presidential Foundation — was organized for the tax-exempt
purposes of operating a presidential archive and research facility
in Little Rock, Arkansas, the analyst recalled.
"These tax-exempt purposes are set forth in the Articles
of Incorporation, which have never been amended to expand such
purposes to include 'fighting HIV/AIDS internationally'," he highlighted.
"Moreover, when the
Clinton Foundation is said to have started fighting HIV/AIDS
internationally by July 2002, Bill Clinton and Ira Magaziner (those who
claim to have led these efforts) were not listed as trustees,
directors, or officers of the Clinton Foundation so it is not clear they
had any valid legal authority to bind the Clinton Foundation in these
supposed endeavors," Ortel explained.
He pointed out that in accordance with US law,
a charity's activities should be transparent for both the
government and the public — something that the
Clinton Foundation could never boast.
Furthermore, US charities wishing to operate internationally and
to offer donors the valid right to deduct contributions supporting
these activities usually must comply with even stricter regulations
than those that apply to American charities working on US soil.
"Never having amended
its Articles of Incorporation, using persons whose roles are not clearly
defined and explained and failing to report the financial consequences
of activities (inside and outside the United States) are each fatal
flaws in any argument asserting that the Clinton Foundation HIV/AIDS
Initiative was, at any time, legally organized, anywhere," Ortel stressed.
However, it was only the beginning.
'Affordable'
HIV/AIDS Treatment and Adulterated Drugs
To tackle the HIV/AIDS problem, the Clinton Foundation
declared its commitment to provide lifesaving treatment to millions
of people, mostly in developing countries. That pledge required a
dramatic reduction in the cost of HIV and AIDS drugs.
In October 2003 the charity inked
agreements with four antiretroviral (ARV) drug
manufacturers: Aspen Pharmacare Holdings Ltd. of Johannesburg, South
Africa; Cipla Ltd., of Mumbai, India; Ranbaxy Laboratories Ltd,
of Delhi, India; and Matrix Laboratories Ltd. of Hyderabad, India.
At the same time, the Clintons had made every effort
to receive substantial funding for their project from both domestic
and foreign sponsors.
However, there is no information on whether or not the
Clinton Foundation had a well-trained medical staff to kick off its
HIV/AIDS initiative.
"It is possible that the
Clinton HIV/AIDS effort used some qualified medical professionals
to direct its supposed work from July 2002 forward but so far
the Clinton Foundation has refused to provide required evidence
to the general public," Ortel noted.
"Bill Clinton has legendary capabilities to raise money,
but no specific experience leading international health care efforts and
no medical credentials," he remarked.
Likewise, the analyst
emphasized, there is no evidence of any kind concerning the testing
of HIV/AIDS drugs distributed by CHAI in the period
from July 2002 through March 23, 2004 and no concrete evidence anyone
can verify that the parent Clinton Foundation was legally in position
to control the HIV/AIDS Initiatives anywhere in the world.
"Surprisingly, federal, state and international regulators have
yet to make an issue of these seemingly bold violations
of applicable laws," he noted.`
And here is the rub, because one of the Clinton Foundation's most endorsed
suppliers of HIV/AIDS medications — Indian firm Ranbaxy
Laboratories Limited — was later found
guilty of selling ineffective,
"adulterated" drugs to its customers.
"In theory, the antiretroviral (ARV) drugs distributed
as part of CHAI's 'work' were generic, rather than branded
versions, and manufactured chiefly in India but also in South
Africa using 'active pharmaceutical ingredients' made primarily in China,"
he said.
"Experienced
professionals generally question when a supplier offers substantial discounts
for products such as generic ARVs," Ortel
remarked.
However, Bill Clinton has never cast doubt on the
quality of Ranbaxy's medication regardless of the fact that
in August 2004 Ranbaxy's three main antiretrovirals were removed from the
World Health Organization's (WHO) prequalification list. Moreover, the US
President's Emergency Plan for AIDS relief (PEPFAR) dropped the
Indian firm from its recommended list in 2008.
What is even more
surprising is that a month before the US
Department of Justice finalized its lengthy investigation,
with Ranbaxy pleading guilty of manufacturing and distributing
adulterated drugs, Bill Clinton praised the
firm for its "stellar contribution" to the Clinton
Foundation's "fight" against HIV/AIDS.
"I fail to understand why, and why Bill
Clinton has continued to defend this firm's diabolical public
record," the Wall Street analyst told Sputnik, commenting
on the matter.
"This behavior is even more curious when you understand that the Clinton Foundation apparently signed an agreement
by October 2003 to promote the sale and distribution of Ranbaxy
drugs, that Rajat Gupta (then a senior McKinsey consultant) apparently
was compensating Bill Clinton and reimbursing the Clinton Family
for expenses via an entity called Mindspirit LLC from 2002
through 2008, and that McKinsey and McKinsey executives had close working
ties to Ranbaxy and to others in the generic pharmaceutical industry,"
Ortel elaborated.
Did the Clintons' Effort Bear Any
Fruit?
Given the above, the
question arises whether there is any official evidence that the Clinton
Foundation's efforts to fight HIV/AIDS have borne any fruit?
"I'm
proud of the foundation. I'm proud of the work that it has
done. Nine million people have lower cost HIV/AIDS medicine because of the
work of the Clinton Foundation my husband [Bill Clinton]," former Democratic presidential candidate Hillary Clinton told CNN
on June 8, 2016.
But the devil is always in the details: Ortel argues
that the evidence he had seen "suggests that this claim is
absurd."
According to the
analyst, the sums claimed on Clinton Foundation
filings for 'pharmaceuticals' are a tiny fraction of the annual cost
of treating nine million HIV/AIDS patients, and a nanoscopic
portion of the cumulative cost of treating however many patients may
have been treated since 2002.
To add to the
controversy, the problem is that the so-called
antiretroviral treatment (ART) is not acure for the deadly
disease, it only may (or may not) keep HIV under control
by arresting the weakening of HIV/AIDS patients' immune systems.
On the other hand,
the non-efficient adulterated ARVs could have had a
harmful impact on their health potentially increasing patient mortality
rates.
Meanwhile, "when
you compare amounts disclosed by major governments and foundations
as having been sent towards the Clinton Foundation
with disclosures in [the charity's] documents concerning direct expenses
for 'pharmaceuticals' from 2002 through 2015 (and here I include all
known Clinton Foundation entities), you find that the
Clinton entities appear to have spent hundreds of millions
of dollars less directly on 'pharmaceuticals' than well-intentioned
donors claim they sent," the Wall Street journalist emphasized.
"It appears to me, that donations were likely used
to cover overhead and for purposes other than those intended
which is normally viewed as a serious problem that can lead to stiff
legal penalties and sanctions, including imprisonment," Ortel told
Sputnik.
"So, call me a stickler,
but I see no evidence that can be verified of a theory that the
Clinton Foundation lawfully provided any help anywhere to victims
of HIV/AIDS internationally," he said, "More likely, efforts associated
with the Clinton Foundation may have cause grievous harm, particularly
to those who may have received adulterated ARVs, should this have happened
from 2002 forward."
WHY THE REAL RECORD OF THE
CLINTON'S CHARITY SHOULD BE EXPOSED
On September 20, 2016 Blackburn released a
78-page report entitled: The Clinton Foundation and the
"India Success Story": Self-Serving
Philanthropy, Watered-Down Drugs, and Money in sub-Saharan Africa.
The report's key findings
indicate that the charity likely facilitated the distribution of "watered
down" HIV/AIDS medications in sub-Saharan Africa through CHAI;
the distribution of watered down ARVs may have increased patient
mortality rates; watered down ARVs were purchased with "taxpayer
money through PEPFAR as a result of price agreements, some
of which were likely negotiated by the Clinton Foundation."
Furthermore, according to the report, former President Bill
Clinton "was personally enriched with million dollar consulting
contracts by a friend of convicted felon, and Ranbaxy advocate, Rajat Gupta from 2002-2008."
"It seems to me that the Clintons have used the
cover of their celebrity and political connections successfully
to argue, until now, that any complaints against the Clinton
Foundation are just political," Ortel said.
"For the benefit
of the many US and foreign charities that do try to help
around the world, we need to expose the real record of the
Clinton 'charity' network, and then cause those who have run it to defend
their behavior using hard, independently verified facts," the Wall Street
analyst stressed.
….
----
----
No hay comentarios:
Publicar un comentario